Thompson, E., Landi, D., Lipp, E., Balajonda, B., Herndon, J. I. I., Buckley, E., … Sampson, J. (2020). PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In NEURO-ONCOLOGY (Vol. 22, pp. 37–37).

Thompson, Eric, Daniel Landi, Eric Lipp, Bea Balajonda, James I. I. Herndon, Evan Buckley, Charlene Flahiff, et al. “PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” In NEURO-ONCOLOGY, 22:37–37, 2020.

Thompson E, Landi D, Lipp E, Balajonda B, Herndon JII, Buckley E, et al. PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. In: NEURO-ONCOLOGY. 2020. p. 37–37.

Thompson, Eric, et al. “PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 37–37.

Thompson E, Landi D, Lipp E, Balajonda B, Herndon JII, Buckley E, Flahiff C, Jaggers D, Schroeder K, Randazzo D, Desjardins A, Johnson M, Peters K, Khasraw M, Malinzak M, Mitchell D, Ashley D, Sampson J. PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL. NEURO-ONCOLOGY. 2020. p. 37–37.